Celularity CELU
NASDAQ CELU
$1.43 -0.01 (-0.35%)
At close: Sep 10, 2026 · 4:00 PM EDT

Celularity (CELU) Total Current Liabilities (2018 - 2025)

Celularity's (CELU) quarterly Total Current Liabilities came in at $80.8 million in Q4 2025, up 50.45% year-over-year from $53.7 million in Q4 2024, and up 23.65% quarter-over-quarter from $65.3 million in Q3 2025.

Analysis

Celularity (CELU) Total Current Liabilities (2018 - 2025) Analysis & Trends

Celularity (CELU) has reported Total Current Liabilities for 8 consecutive years, with $80.8 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 50.45% year-over-year to $80.8 million in Q4 2025; TTM through Dec 2025 was $80.8 million, a 50.45% increase from a year earlier, with the FY2025 full-year figure at $80.8 million, up 50.45% from the prior year.
  • Total Current Liabilities was $80.8 million for Q4 2025 at Celularity, up from $65.3 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $84.6 million in Q3 2023 and troughed at $5.2 million in Q1 2021.
  • A 5-year average of $54.0 million and a median of $65.1 million in 2023 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities surged 20571.7% in 2021 and decreased 20.24% in 2024, its largest moves.
  • Over 5 years, Total Current Liabilities stood at $26.2 million in 2021, then surged by 136.75% to $62.1 million in 2022, then grew by 8.39% to $67.3 million in 2023, then declined by 20.24% to $53.7 million in 2024, then jumped by 50.45% to $80.8 million in 2025.
  • The last three Total Current Liabilities figures came in at $80.8 million (Q4 2025), $65.3 million (Q3 2025), and $69.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn 127.40 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn - 132.90 Mn
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn 106.85 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn 403.60 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn 83.35 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn - 80.88 Mn
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn 29.35 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn 502.91 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn 52.53 Mn
10 Celularity 36.35 Mn 30.17 Mn -3.27 Mn 80.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 80.76 Mn
Sep 30, 2025 65.31 Mn
Jun 30, 2025 69.23 Mn
Mar 31, 2025 58.69 Mn
Dec 31, 2024 53.68 Mn
Sep 30, 2024 76.17 Mn
Jun 30, 2024 67.90 Mn
Mar 31, 2024 66.04 Mn
Dec 31, 2023 67.30 Mn
Sep 30, 2023 84.63 Mn
Jun 30, 2023 64.98 Mn
Mar 31, 2023 66.46 Mn
Dec 31, 2022 62.09 Mn
Sep 30, 2022 69.22 Mn
Jun 30, 2022 32.94 Mn
Mar 31, 2022 26.03 Mn
Dec 31, 2021 26.23 Mn
Sep 30, 2021 29.21 Mn
Jun 30, 2021 7.29 Mn
Mar 31, 2021 5.16 Mn